Keywords: Kamada, Cheisi, Alpha-1 antitrypsin, Distribution
Kamada in distribution deal with Chiesi for Europe, Turkey and former CIS countries
Article | 08 August 2012
Israeli biopharma company Kamada (KMDA: TA) has entered into an exclusive agreement with privately-owned Italian drugmaker Chiesi Farmaceutici for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
